Avenzo Therapeutics: Dualitybio to Be Eligible to Receive up to About $1.15 Bln in Development, Regulatory & Commercial Milestone Payments
Avenzo Therapeutics:Dualitybio有资格获得高达约11.5亿美元的开发、监管和商业里程碑付款
Avenzo Therapeutics: Dualitybio to Be Eligible to Receive up to About $1.15 Bln in Development, Regulatory & Commercial Milestone Payments
Avenzo Therapeutics:Dualitybio有资格获得高达约11.5亿美元的开发、监管和商业里程碑付款
使用浏览器的分享功能,分享给你的好友吧